ELIXIR PHARMACEUTICALS
Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Company's scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.
ELIXIR PHARMACEUTICALS
Industry:
Biotechnology Diabetes Pharmaceutical
Founded:
1999-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.elixirpharm.com
Total Employee:
11+
Status:
Closed
Contact:
617-995-7000
Email Addresses:
[email protected]
Total Funding:
98.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Nginx DigiCert SSL CloudFront Google Adsense AdBlock Acceptable Ads Hetzner Google Adsense For Domains Thawte SSL
Founder
Investors List
Omega Funds
Omega Funds investment in Series D - Elixir Pharmaceuticals
Physic Ventures
Physic Ventures investment in Series D - Elixir Pharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Series D - Elixir Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series D - Elixir Pharmaceuticals
MPM Capital
MPM Capital investment in Series D - Elixir Pharmaceuticals
Hercules Capital
Hercules Capital investment in Series C - Elixir Pharmaceuticals
YFY Biotech Management Company
YFY Biotech Management Company investment in Series C - Elixir Pharmaceuticals
Hercules Capital
Hercules Capital investment in Debt Financing - Elixir Pharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Elixir Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series C - Elixir Pharmaceuticals
Official Site Inspections
http://www.elixirpharm.com
- Host name: 66-175-209-179.ip.linodeusercontent.com
- IP address: 66.175.209.179
- Location: Newark United States
- Latitude: 40.8229
- Longitude: -74.4592
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07927
More informations about "Elixir Pharmaceuticals"
Elixir Pharmaceuticals - Crunchbase Company Profile
Contact Email [email protected] Phone Number 617-995-7000 Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, …See details»
Elixirpharm, S.R.O. Company Profile - Slovakia - EMIS
Oct 23, 2024 Elixirpharm, S.R.O. is based in Slovakia, with the head office in Spisska Nova Ves. It operates in the Real Estate sector. The company was established on September 09, 2009. In its most recent financial highlights, the company reported a net sales revenue increase of 38.9% in 2023. Its total assets decreased by 18.75% over the same period.See details»
Elixir Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 320 Putnam Avenue . Cambridge, Massachusetts, 02139, United States. 617-225-2686See details»
Elixir Pharmaceuticals, Inc - VentureRadar
Similar Companies: Lohocla Research Corporation USA Privately Held Lohocla Research Corporation uses genetic and genomic technology and biochemical and molecular biology approaches, in conjunction with rational computational drug design to develop diagnostic and therapeutic products for chronic pain, neurologic mental illness, and addictive disorders. . …See details»
ELIXIRPHARM LTD overview - Find and update company …
ELIXIRPHARM LTD. Company number 10986544. Follow this company Company Overview for ELIXIRPHARM LTD (10986544) Filing history for ELIXIRPHARM LTD (10986544) People for ELIXIRPHARM LTD (10986544) More for ELIXIRPHARM LTD (10986544) Registered office address 3rd Floor, 120 Baker Street, London, England, W1U 6TU ...See details»
Elixir Pharmaceuticals | Company | Mindmaps
Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity.See details»
Elixir Pharmaceuticals, Inc. (Elixir Pharmaceuticals, Inc.) - 药物管线_ …
“I am honored to join such a dynamic organization, and excited about becoming a part of the excellent leadership team.” About Elixir Medical Elixir Medical Corporation, a privately-funded company based in Milpitas, California, develops next-generation platforms to treat coronary and peripheral artery disease that are designed to restore the adaptive remodeling and pulsatile …See details»
Consultation and Clinical Advisory Board Agreement with Bennett …
Therefore, for the duration of the Consultation Period and for two (2) years thereafter, the Advisor shall not engage in any activities that would compete with the Company—including without limitation becoming employed by, serving as a consultant for, serving as a member of a scientific or clinical advisory board (or a comparable organization) for, or acting in any manner on behalf …See details»
Articles about Elixir Pharmaceuticals - BioSpace
Sep 18, 2008 Elixir Pharmaceuticals to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference. 2/7/2008. Elixir Pharmaceuticals Sees IPO of 5 Million Shares at $14-$16 each. 12/18/2007. Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer. 10/25/2007. Elixir Pharmaceuticals Plans $86.25 Million IPO. 9/24/2007See details»
ELIXIRPHARM, s.r.o. - zisk, tržby, hospodárske výsledky a účtovné …
Spoločnosť ELIXIRPHARM, s.r.o. sa v roku 2022 dostala do zisku z -763 € na 19 070 € a tržby jej narástli o 848 % na 2,052 mil. €. IČO 36864510 DIČ 2022888087See details»
Elixirpharm : elixirpharm.com
Dec 30, 2023 elixirpharm.com is 1 decade 11 months old. It is a domain having com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, elixirpharm.com is SAFE to browse. Updated 3 years 11 months ago Update StatSee details»
Elixir Pharmaceuticals - CB Insights
Explore {Elixir Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
What is Elixir Pharmaceuticals? Company Culture, Mission, Values
See what employees say it's like to work at Elixir Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Elixir Pharmaceuticals.See details»
Elixir Pharma - Products, Competitors, Financials, Employees ...
Elixir Pharma is a company focused on the research and development of medical products, specifically in the biotechnology and pharmaceutical industry. Use the CB Insights Platform to explore Elixir Pharma's full profile.See details»
More Efficiency, Service and Value on the Horizon as ... - Business …
Mar 19, 2020 The increased integration will give payers, patients and Medicare Part D members access to the best products and services from across the pharmacy benefits and service company’s portfolio.See details»
EnvisionRx and MedTrakRx are now Elixir!
EnvisionRx and MedTrakRx are now Elixir! As a pharmacy in our network, you are an important partner in helping us deliver medications to our members.See details»
Elixir Pharma – elexirpharma.se
Vi tillverkar kosttillskott för alla de tillfällen då livet kommer emellan, ja för livets alla brister. Både för dig och för alla du tycker om. Våra produkter skapas för livets alla faser och cykler, för att ge en mer positiv effekt på hälsan. Elexir Pharma har kosttillskott för hela livet.See details»
EnvisionRxOptions is Now Elixir - elixirsolutions
March 19, 2020 - EnvisionRxOptions, a wholly owned subsidiary of Rite Aid Corporation, announced it will further integrate its pharmacy benefits, services and technology companies, rebranding under the new name, Elixir.See details»
Integration of EnvisionRxOptions' Businesses to Elixir Continues …
EnvisionRx is mixing things up and on September 1, we will be known as Elixir. This rebrand is more than just a new name, however. It is a true integration that is blending the best of all EnvisionRxOptions’ individual brands into one integrated organization that improves efficiencies and offers best-in-class solutions for our clients and members.See details»
Elixir Formulary Decisions Deliver on Member Whole-Being Health
Prescription drug spend represented 13.7% of national health expenditures in 2018, totaling $500 billion, and is expected to grow to $863 billion by 2028. Formularies remain a staple in trying to manage these costs; however, payers often worry about the impact on members.See details»